222 related articles for article (PubMed ID: 12907655)
1. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
2. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
4. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
6. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
[TBL] [Abstract][Full Text] [Related]
7. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
[TBL] [Abstract][Full Text] [Related]
9. [Biological mechanism of full-length form of spleen tyrosine kinase regulating gene transcription in breast cancer cells].
Wang L; Hu Y; Yang ZL; Song XM; Wang JP
Ai Zheng; 2007 May; 26(5):469-72. PubMed ID: 17672934
[TBL] [Abstract][Full Text] [Related]
10. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.
Flück M; Zürcher G; Andres AC; Ziemiecki A
Biochem Biophys Res Commun; 1995 Aug; 213(1):273-81. PubMed ID: 7639745
[TBL] [Abstract][Full Text] [Related]
12. Syk: a new player in the field of breast cancer.
Stewart ZA; Pietenpol JA
Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739
[TBL] [Abstract][Full Text] [Related]
13. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
14. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
15. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
Inayat U; Kayani MA; Faryal R
Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
[TBL] [Abstract][Full Text] [Related]
16. A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling.
Latour S; Zhang J; Siraganian RP; Veillette A
EMBO J; 1998 May; 17(9):2584-95. PubMed ID: 9564041
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
18. Expression of Syk in invasive breast cancer: correlation to proliferation and invasiveness.
Repana K; Papazisis K; Foukas P; Valeri R; Kortsaris A; Deligiorgi E; Kyriakidis D
Anticancer Res; 2006; 26(6C):4949-54. PubMed ID: 17214368
[TBL] [Abstract][Full Text] [Related]
19. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
20. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
Zhang J; Siraganian RP
J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]